{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T17:18:49Z","timestamp":1787159929645,"version":"build-2736575974"},"reference-count":49,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2015,1,1]],"date-time":"2015-01-01T00:00:00Z","timestamp":1420070400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,10,7]],"date-time":"2016-10-07T00:00:00Z","timestamp":1475798400000},"content-version":"vor","delay-in-days":645,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecular Therapy"],"published-print":{"date-parts":[[2015,1]]},"DOI":"10.1038\/mt.2014.175","type":"journal-article","created":{"date-parts":[[2014,9,8]],"date-time":"2014-09-08T07:18:03Z","timestamp":1410160683000},"page":"17-23","source":"Crossref","is-referenced-by-count":93,"title":["Fractalkine Over Expression Suppresses \u03b1-Synuclein-mediated Neurodegeneration"],"prefix":"10.1016","volume":"23","author":[{"given":"Kevin R","family":"Nash","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Moran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dylan J","family":"Finneran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles","family":"Hudson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jesse","family":"Robinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dave","family":"Morgan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paula C","family":"Bickford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1038\/mt.2014.175_bib1","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1189\/jlb.0507296","article-title":"Neuroprotective activities of CD4+CD25+ regulatory T cells in an animal model of Parkinson's disease","volume":"82","author":"Reynolds","year":"2007","journal-title":"J Leukoc Biol"},{"key":"10.1038\/mt.2014.175_bib2","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1096\/fj.04-2751com","article-title":"Aggregated alpha-synuclein activates microglia: a process leading to disease progression in Parkinson's disease","volume":"19","author":"Zhang","year":"2005","journal-title":"FASEB J"},{"key":"10.1038\/mt.2014.175_bib3","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/s11481-013-9435-y","article-title":"Neural and immune mechanisms in the pathogenesis of Parkinson's disease","volume":"8","author":"Blandini","year":"2013","journal-title":"J Neuroimmune Pharmacol"},{"key":"10.1038\/mt.2014.175_bib4","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1007\/s11481-012-9401-0","article-title":"Microglial activation and antioxidant responses induced by the Parkinson's disease protein \u03b1-synuclein","volume":"8","author":"B\u00e9raud","year":"2013","journal-title":"J Neuroimmune Pharmacol"},{"key":"10.1038\/mt.2014.175_bib5","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.jneuroim.2008.04.012","article-title":"Neuron-microglia signaling: chemokines as versatile messengers","volume":"198","author":"Biber","year":"2008","journal-title":"J Neuroimmunol"},{"key":"10.1038\/mt.2014.175_bib6","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1038\/nn1997","article-title":"Microglia: active sensor and versatile effector cells in the normal and pathologic brain","volume":"10","author":"Hanisch","year":"2007","journal-title":"Nat Neurosci"},{"key":"10.1038\/mt.2014.175_bib7","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.tins.2005.12.005","article-title":"Microglial phenotype: is the commitment reversible?","volume":"29","author":"Schwartz","year":"2006","journal-title":"Trends Neurosci"},{"key":"10.1038\/mt.2014.175_bib8","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.tins.2007.08.007","article-title":"Neuronal \u2018On\u2019 and \u2018Off\u2019 signals control microglia","volume":"30","author":"Biber","year":"2007","journal-title":"Trends Neurosci"},{"key":"10.1038\/mt.2014.175_bib9","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.it.2006.11.004","article-title":"What is immune privilege (not)?","volume":"28","author":"Galea","year":"2007","journal-title":"Trends Immunol"},{"key":"10.1038\/mt.2014.175_bib10","doi-asserted-by":"crossref","first-page":"2030","DOI":"10.1016\/j.neurobiolaging.2009.11.022","article-title":"Fractalkine and CX 3 CR1 regulate hippocampal neurogenesis in adult and aged rats","volume":"32","author":"Bachstetter","year":"2011","journal-title":"Neurobiol Aging"},{"key":"10.1038\/mt.2014.175_bib11","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1742-2094-8-9","article-title":"CX3CL1 reduces neurotoxicity and microglial activation in a rat model of Parkinson's disease","volume":"8","author":"Pabon","year":"2011","journal-title":"J Neuroinflammation"},{"key":"10.1038\/mt.2014.175_bib12","doi-asserted-by":"crossref","first-page":"10896","DOI":"10.1073\/pnas.95.18.10896","article-title":"Role for neuronally derived fractalkine in mediating interactions between neurons and CX3CR1-expressing microglia","volume":"95","author":"Harrison","year":"1998","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/mt.2014.175_bib13","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0074-7742(07)82010-1","article-title":"Chemokines and chemokine receptors: multipurpose players in neuroinflammation","volume":"82","author":"Ransohoff","year":"2007","journal-title":"Int Rev Neurobiol"},{"key":"10.1038\/mt.2014.175_bib14","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1016\/j.bbi.2010.05.011","article-title":"Protracted downregulation of CX3CR1 on microglia of aged mice after lipopolysaccharide challenge","volume":"24","author":"Wynne","year":"2010","journal-title":"Brain Behav Immun"},{"key":"10.1038\/mt.2014.175_bib15","doi-asserted-by":"crossref","first-page":"7478","DOI":"10.4049\/jimmunol.179.11.7478","article-title":"Dose-dependent differential regulation of cytokine secretion from macrophages by fractalkine","volume":"179","author":"Mizutani","year":"2007","journal-title":"J Immunol"},{"key":"10.1038\/mt.2014.175_bib16","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1111\/j.1471-4159.2009.06253.x","article-title":"Fractalkine-induced activation of the phosphatidylinositol-3 kinase pathway attentuates microglial activation in vivo and in vitro","volume":"110","author":"Lyons","year":"2009","journal-title":"J Neurochem"},{"key":"10.1038\/mt.2014.175_bib17","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.4049\/jimmunol.163.3.1628","article-title":"Characterization of fractalkine in rat brain cells: migratory and activation signals for CX3CR-1-expressing microglia","volume":"163","author":"Maciejewski-Lenoir","year":"1999","journal-title":"J Immunol"},{"key":"10.1038\/mt.2014.175_bib18","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1038\/nn0706-859","article-title":"Fractalkine: moving from chemotaxis to neuroprotection","volume":"9","author":"R\u00e9","year":"2006","journal-title":"Nat Neurosci"},{"key":"10.1038\/mt.2014.175_bib19","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1002\/(SICI)1098-1136(20000215)29:4<305::AID-GLIA2>3.0.CO;2-V","article-title":"Fractalkine modulates TNF-alpha secretion and neurotoxicity induced by microglial activation","volume":"29","author":"Zujovic","year":"2000","journal-title":"Glia"},{"key":"10.1038\/mt.2014.175_bib20","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1002\/jlb.67.4.577","article-title":"NF-kappaB-dependent fractalkine induction in rat aortic endothelial cells stimulated by IL-1beta, TNF-alpha, and LPS","volume":"67","author":"Garcia","year":"2000","journal-title":"J Leukoc Biol"},{"key":"10.1038\/mt.2014.175_bib21","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1160\/TH07-01-0035","article-title":"Transmembrane chemokines: versatile \u2018special agents\u2019 in vascular inflammation","volume":"97","author":"Ludwig","year":"2007","journal-title":"Thromb Haemost"},{"key":"10.1038\/mt.2014.175_bib22","doi-asserted-by":"crossref","first-page":"37993","DOI":"10.1074\/jbc.M106434200","article-title":"Tumor necrosis factor-alpha-converting enzyme (ADAM17) mediates the cleavage and shedding of fractalkine (CX3CL1)","volume":"276","author":"Garton","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1038\/mt.2014.175_bib23","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1182\/blood-2002-12-3775","article-title":"The disintegrin-like metalloproteinase ADAM10 is involved in constitutive cleavage of CX3CL1 (fractalkine) and regulates CX3CL1-mediated cell-cell adhesion","volume":"102","author":"Hundhausen","year":"2003","journal-title":"Blood"},{"key":"10.1038\/mt.2014.175_bib24","doi-asserted-by":"crossref","first-page":"RC87","DOI":"10.1523\/JNEUROSCI.20-15-j0004.2000","article-title":"Fractalkine cleavage from neuronal membranes represents an acute event in the inflammatory response to excitotoxic brain damage","volume":"20","author":"Chapman","year":"2000","journal-title":"J Neurosci"},{"key":"10.1038\/mt.2014.175_bib25","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/S0092-8674(00)80438-9","article-title":"Identification and molecular characterization of fractalkine receptor CX3CR1, which mediates both leukocyte migration and adhesion","volume":"91","author":"Imai","year":"1997","journal-title":"Cell"},{"key":"10.1038\/mt.2014.175_bib26","doi-asserted-by":"crossref","first-page":"e156","DOI":"10.1182\/blood-2011-04-348946","article-title":"In vivo structure\/function and expression analysis of the CX3C chemokine fractalkine","volume":"118","author":"Kim","year":"2011","journal-title":"Blood"},{"key":"10.1038\/mt.2014.175_bib27","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1002\/immu.200390007","article-title":"Membrane-bound form of fractalkine induces IFN-gamma production by NK cells","volume":"33","author":"Yoneda","year":"2003","journal-title":"Eur J Immunol"},{"key":"10.1038\/mt.2014.175_bib28","doi-asserted-by":"crossref","first-page":"2549","DOI":"10.2353\/ajpath.2010.100265","article-title":"CX3CR1 deficiency alters microglial activation and reduces beta-amyloid deposition in two Alzheimer's disease mouse models","volume":"177","author":"Lee","year":"2010","journal-title":"Am J Pathol"},{"key":"10.1038\/mt.2014.175_bib29","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.neuron.2010.08.023","article-title":"Regulation of tau pathology by the microglial fractalkine receptor","volume":"68","author":"Bhaskar","year":"2010","journal-title":"Neuron"},{"key":"10.1038\/mt.2014.175_bib30","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1016\/j.neurobiolaging.2012.12.011","article-title":"Fractalkine overexpression suppresses tau pathology in a mouse model of tauopathy","volume":"34","author":"Nash","year":"2013","journal-title":"Neurobiol Aging"},{"key":"10.1038\/mt.2014.175_bib31","doi-asserted-by":"crossref","first-page":"14592","DOI":"10.1523\/JNEUROSCI.0539-12.2012","article-title":"The soluble isoform of CX3CL1 is necessary for neuroprotection in a mouse model of Parkinson's disease","volume":"32","author":"Morganti","year":"2012","journal-title":"J Neurosci"},{"key":"10.1038\/mt.2014.175_bib32","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1073\/pnas.0711053105","article-title":"The phosphorylation state of Ser-129 in human alpha-synuclein determines neurodegeneration in a rat model of Parkinson disease","volume":"105","author":"Gorbatyuk","year":"2008","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/mt.2014.175_bib33","doi-asserted-by":"crossref","first-page":"e45256","DOI":"10.1371\/journal.pone.0045256","article-title":"A spirulina-enhanced diet provides neuroprotection in an \u03b1-synuclein model of Parkinson's disease","volume":"7","author":"Pabon","year":"2012","journal-title":"PLoS One"},{"key":"10.1038\/mt.2014.175_bib34","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.jneumeth.2010.10.010","article-title":"Convection-enhanced delivery and systemic mannitol increase gene product distribution of AAV vectors 5, 8, and 9 and increase gene product in the adult mouse brain","volume":"194","author":"Carty","year":"2010","journal-title":"J Neurosci Methods"},{"key":"10.1038\/mt.2014.175_bib35","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.ymthe.2004.05.024","article-title":"Recombinant AAV viral vectors pseudotyped with viral capsids from serotypes 1, 2, and 5 display differential efficiency and cell tropism after delivery to different regions of the central nervous system","volume":"10","author":"Burger","year":"2004","journal-title":"Mol Ther"},{"key":"10.1038\/mt.2014.175_bib36","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1038\/sj.mt.6300331","article-title":"AAV8, 9, Rh10, Rh43 vector gene transfer in the rat brain: effects of serotype, promoter and purification method","volume":"16","author":"Klein","year":"2008","journal-title":"Mol Ther"},{"key":"10.1038\/mt.2014.175_bib37","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1038\/nn1715","article-title":"Control of microglial neurotoxicity by the fractalkine receptor","volume":"9","author":"Cardona","year":"2006","journal-title":"Nat Neurosci"},{"key":"10.1038\/mt.2014.175_bib38","doi-asserted-by":"crossref","first-page":"14592","DOI":"10.1523\/JNEUROSCI.0539-12.2012","article-title":"The soluble isoform of CX3CL1 is necessary for neuroprotection in a mouse model of Parkinson's disease","volume":"32","author":"Morganti","year":"2012","journal-title":"J Neurosci"},{"key":"10.1038\/mt.2014.175_bib39","doi-asserted-by":"crossref","first-page":"5305","DOI":"10.1016\/j.biomaterials.2009.06.018","article-title":"Generating substrate bound functional chemokine gradients in vitro","volume":"30","author":"Hjort\u00f8","year":"2009","journal-title":"Biomaterials"},{"key":"10.1038\/mt.2014.175_bib40","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1038\/mt.2009.170","article-title":"Efficient gene delivery and selective transduction of glial cells in the mammalian brain by AAV serotypes isolated from nonhuman primates","volume":"17","author":"Lawlor","year":"2009","journal-title":"Mol Ther"},{"key":"10.1038\/mt.2014.175_bib41","doi-asserted-by":"crossref","first-page":"e65646","DOI":"10.1371\/journal.pone.0065646","article-title":"Glial promoter selectivity following AAV-delivery to the immature brain","volume":"8","author":"von Jonquieres","year":"2013","journal-title":"PLoS One"},{"key":"10.1038\/mt.2014.175_bib42","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1016\/j.neurobiolaging.2012.12.014","article-title":"Aging enhances classical activation but mitigates alternative activation in the central nervous system","volume":"34","author":"Lee","year":"2013","journal-title":"Neurobiol Aging"},{"key":"10.1038\/mt.2014.175_bib43","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.pneurobio.2010.06.009","article-title":"Microglia and neuroprotection: from in vitro studies to therapeutic applications","volume":"92","author":"Polazzi","year":"2010","journal-title":"Prog Neurobiol"},{"key":"10.1038\/mt.2014.175_bib44","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.brainresrev.2004.12.013","article-title":"Microglia and neuroprotection: implications for Alzheimer's disease","volume":"48","author":"Streit","year":"2005","journal-title":"Brain Res Brain Res Rev"},{"key":"10.1038\/mt.2014.175_bib45","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1002\/mds.25344","article-title":"Trophic factor gene therapy for Parkinson's disease","volume":"28","author":"Kordower","year":"2013","journal-title":"Mov Disord"},{"key":"10.1038\/mt.2014.175_bib46","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.nbd.2004.06.008","article-title":"Lentiviral nigral delivery of GDNF does not prevent neurodegeneration in a genetic rat model of Parkinson's disease","volume":"17","author":"Lo Bianco","year":"2004","journal-title":"Neurobiol Dis"},{"issue":"Pt 8","key":"10.1038\/mt.2014.175_bib47","doi-asserted-by":"crossref","first-page":"2302","DOI":"10.1093\/brain\/awr149","article-title":"GDNF fails to exert neuroprotection in a rat \u03b1-synuclein model of Parkinson's disease","volume":"134","author":"Decressac","year":"2011","journal-title":"Brain"},{"key":"10.1038\/mt.2014.175_bib48","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.expneurol.2007.08.006","article-title":"In vivo alpha-synuclein overexpression in rodents: a useful model of Parkinson's disease?","volume":"209","author":"Chesselet","year":"2008","journal-title":"Exp Neurol"},{"key":"10.1038\/mt.2014.175_bib49","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1038\/mt.2010.115","article-title":"In vivo RNAi-mediated alpha-synuclein silencing induces nigrostriatal degeneration","volume":"18","author":"Gorbatyuk","year":"2010","journal-title":"Mol Ther"}],"container-title":["Molecular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001616300065?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001616300065?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,7,16]],"date-time":"2023-07-16T08:33:03Z","timestamp":1689496383000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525001616300065"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,1]]},"references-count":49,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,1]]}},"alternative-id":["S1525001616300065"],"URL":"https:\/\/doi.org\/10.1038\/mt.2014.175","relation":{},"ISSN":["1525-0016"],"issn-type":[{"value":"1525-0016","type":"print"}],"subject":[],"published":{"date-parts":[[2015,1]]}}}